Showing results (51-60 of 271) with videos related to
Sort By:
Pageof 28
Diabetes|September 11, 2012
Overexpression of sphingosine kinase 1 prevents ceramide accumulation and ameliorates muscle insulin resistance in high-fat diet-fed miceClinton R Bruce, Steve Risis, Joanne R Babb, et al.The Journal of Endocrinology|June 5, 2008
Prolonged interleukin-6 administration enhances glucose tolerance and increases skeletal muscle PPARalpha and UCP2 expression in ratsAnna G Holmes, Jose L Mesa, Bronwyn A Neill, et al.British Journal of Pharmacology|March 2, 2019
Metabolic control and sex: A focus on inflammatory-linked mediatorsDarren C Henstridge, Julie Abildgaard, Birgitte Lindegaard, et al.Cells|October 1, 2020
The Protective Effect of Exercise in Neurodegenerative Diseases: The Potential Role of Extracellular VesiclesOliver K Fuller, Martin Whitham, Suresh Mathivanan, et al.The Journal of Physiology|March 19, 2005
AMP kinase activation with AICAR further increases fatty acid oxidation and blunts triacylglycerol hydrolysis in contracting rat soleus muscleAngela C Smith, Clinton R Bruce, David J DyckThe Journal of Physiology|March 19, 2005
AMP kinase activation with AICAR simultaneously increases fatty acid and glucose oxidation in resting rat soleus muscleAngela C Smith, Clinton R Bruce, David J DyckMetabolism: Clinical and Experimental|December 12, 2003
Regulation of glucose kinetics during intense exercise in humans: effects of alpha- and beta-adrenergic blockadeKirsten F Howlett, Matthew J Watt, Mark Hargreaves, et al.Endocrinology|January 7, 2006
Ciliary neurotrophic factor prevents acute lipid-induced insulin resistance by attenuating ceramide accumulation and phosphorylation of c-Jun N-terminal kinase in peripheral tissuesMatthew J Watt, Andrea Hevener, Graeme I Lancaster, et al.Canadian Journal of Physiology and Pharmacology|September 26, 2006
AMP-activated protein kinase--the fat controller of the energy railroadGregory R Steinberg, S Lance Macaulay, Mark A Febbraio, et al.Iscience|January 24, 2023
Diet-induced gut dysbiosis and inflammation: Key drivers of obesity-driven NASHGideon G Kang, Natalie L Trevaskis, Andrew J Murphy, et al.Pageof 28